Scotlands Green Datacentre Policy Faces Scrutiny Over AI Emissions Impact Analysis Shows Singtel Shares Decline on Weak Singapore Business as Telco Reaffirms Optus Commitment Powell Vows No Shadow Chair Role but Potential Conflict with Warsh Looms SoFi Technologies Reports Quarterly Results Key Metrics Under Market Scrutiny Tennessee Enacts FAIR Rx Act Prohibiting PBM Ownership of Pharmacies TPA and NCPA Applaud Trump Administration Maintains Iran Naval Blockade Until Agreement Reached President Dismisses Critics REVB Q1 2026 Earnings Staggering EPS Miss Highlights Ongoing Clinical Development Costs Gladstone Land Corporation LANDP Q1 2026 Earnings Preferred Shares Beat Estimates Despite Negative EPS NEXN Q3 2025 Earnings Strong EPS Beat Drives Positive Stock Reaction HLIT Q1 2026 Earnings Significant EPS Beat Driven by Operational Efficiencies RERE Q1 2026 Earnings EPS Surprises by 1832 But Stock Declines 507 Fennec Pharmaceuticals Q1 2026 Earnings EPS Surprise Beats Estimates Amidst PreRevenue Stage IBEX Limited IBEX Advances 19 as Shares Test Key Resistance Level TMobile US Senior Notes TMUSI Inch Higher as Bond Market Stabilizes Village Super Market VLGEA Surges 329 as Shares Approach Key Resistance Crane Harbor Acquisition Corp II Rights CRANR Drifts Sideways at 021 Support and Resistance Tighten Sempra SRE Slips 135 Utility Stock Tests Key Support Zone Lidl Overtakes Morrisons to Become Britains FifthLargest Supermarket Hour Loop Inc HOUR Q4 2024 Earnings Narrowing Loss Amid Quiet Quarter Gabelli Global Small and Mid Cap Value Trust GGZ Edges Higher in Quiet Trading BlackRock Credit Allocation Income Trust BTZ Inches Higher as YieldDriven Trading Continues Definium Therapeutics DFTX Slips 066 as Shares Test Key Support Zone Resideo Technologies REZI Gains 114 as Stock Approaches Key Resistance Pilgrims Pride PPC Edges Lower Amid Sector Pressure Holding Above Key Support CEA Industries Inc BNC Holds Steady Near Support as Shares Edge Higher Lennox International LII Holds Steady Near 503 Consolidating Within Recent Range Neumora Therapeutics NMRA Holds Steady at 185 Amid Mixed Sentiment